BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 28625605)

  • 1. Population-based assessment of relationship between volume of practice and outcomes in head and neck cancer patients treated in a provincially coordinated radiotherapy program.
    McLay M; Stedford A; Yurkowski E; Matlock S; Cheung W; Tran E; Berthelet E; Wu J; Olson R
    Radiother Oncol; 2017 Jul; 124(1):174-181. PubMed ID: 28625605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Patterns in Elderly Head and Neck Squamous Cell Carcinoma Patients Treated With Definitive Radiation Therapy.
    Sommers LW; Steenbakkers RJHM; Bijl HP; Vemer-van den Hoek JGM; Roodenburg JLN; Oosting SF; Halmos GB; de Rooij SE; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):793-801. PubMed ID: 28476434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in head and neck cancer care in the Netherlands: A retrospective cohort evaluation of incidence, treatment and outcome.
    de Ridder M; Balm AJM; Baatenburg de Jong RJ; Terhaard CHJ; Takes RP; Slingerland M; Dik E; Sedee RJE; de Visscher JGAM; Bouman H; Willems SM; Wouters MW; Smeele LE; van Dijk BAC;
    Eur J Surg Oncol; 2017 Aug; 43(8):1494-1502. PubMed ID: 28336186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy.
    Boero IJ; Paravati AJ; Xu B; Cohen EE; Mell LK; Le QT; Murphy JD
    J Clin Oncol; 2016 Mar; 34(7):684-90. PubMed ID: 26729432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urban and rural differences in outcomes of head and neck cancer.
    Kim JD; Firouzbakht A; Ruan JY; Kornelsen E; Moghaddamjou A; Javaheri KR; Olson RA; Cheung WY
    Laryngoscope; 2018 Apr; 128(4):852-858. PubMed ID: 28940575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ninety-day mortality after radiotherapy for head and neck cancer: Population-based comparison between rural and urban patients.
    Schlijper R; Bos S; Hamilton SN; Tran E; Berthelet E; Wu J; Olson RA
    Head Neck; 2021 Nov; 43(11):3306-3313. PubMed ID: 34288200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years.
    Tiwana MS; Hay J; Wu J; Wong F; Cheung W; Olson RA
    Laryngoscope; 2014 Oct; 124(10):2287-91. PubMed ID: 24729185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
    Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S
    Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective study of palliative radiotherapy in newly diagnosed head and neck carcinoma.
    Stevens CM; Huang SH; Fung S; Bayley AJ; Cho JB; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; O'Sullivan B; Waldron JN; Ringash J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):958-63. PubMed ID: 20950952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and survival of second primary early-stage lung cancer, following treatment of head and neck cancer in the Netherlands.
    Louie AV; Damhuis RA; Haasbeek CJ; Warner A; Rodin D; Slotman BJ; Leemans CR; Senan S
    Lung Cancer; 2016 Apr; 94():54-60. PubMed ID: 26973207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of single- versus multiple-fraction palliative radiation therapy for bone metastases: population-based analysis of 16,898 courses in a Canadian province.
    Olson RA; Tiwana MS; Barnes M; Kiraly A; Beecham K; Miller S; Hoegler D; Olivotto I
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1092-1099. PubMed ID: 25035213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of treatment institution in head and neck cancer radiotherapy.
    Kubicek GJ; Wang F; Reddy E; Shnayder Y; Cabrera CE; Girod DA
    Otolaryngol Head Neck Surg; 2009 Aug; 141(2):172-6. PubMed ID: 19643247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated With Survival in Patients With Synovial Cell Sarcoma of the Head and Neck: An Analysis of 167 Cases Using the SEER (Surveillance, Epidemiology, and End Results) Database.
    Mallen-St Clair J; Arshi A; Abemayor E; St John M
    JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):576-83. PubMed ID: 27100936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival in patients with Stage III-IV Head and neck cancer treated with radiotherapy as primary local treatment modality.
    Rusthoven KE; Raben D; Chen C
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):343-50. PubMed ID: 18374508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second course of radiation for new primary head-and-neck cancer: population-based study of survival.
    Milano MT; Zhang H
    Am J Clin Oncol; 2011 Aug; 34(4):367-71. PubMed ID: 20859195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of total radiotherapy dose on survival for head and neck Merkel cell carcinoma after resection.
    Patel SA; Qureshi MM; Mak KS; Sahni D; Giacalone NJ; Ezzat W; Jalisi S; Truong MT
    Head Neck; 2017 Jul; 39(7):1371-1377. PubMed ID: 28370725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of stage III colon cancer in the elderly: Practice patterns and outcomes in the general population.
    Merchant SJ; Nanji S; Brennan K; Karim S; Patel SV; Biagi JJ; Booth CM
    Cancer; 2017 Aug; 123(15):2840-2849. PubMed ID: 28346663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which is the most suitable lymph node predictor for overall survival after primary surgery of head and neck cancer: pN, the number or the ratio of positive lymph nodes, or log odds?
    Yildiz MM; Petersen I; Eigendorff E; Schlattmann P; Guntinas-Lichius O
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):885-93. PubMed ID: 26711282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent dysphagia after head and neck radiotherapy: a common and under-reported complication with significant effect on non-cancer-related mortality.
    Szczesniak MM; Maclean J; Zhang T; Graham PH; Cook IJ
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):697-703. PubMed ID: 25239671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.